 Kelli Money
Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smallpox Vaccine | 1 | 2023 | 23 | 0.770 |
Why?
| | Optic Neuritis | 1 | 2023 | 44 | 0.750 |
Why?
| | Central Nervous System Diseases | 1 | 2023 | 74 | 0.720 |
Why?
| | Demyelinating Autoimmune Diseases, CNS | 1 | 2021 | 4 | 0.690 |
Why?
| | Immunologic Factors | 1 | 2021 | 260 | 0.580 |
Why?
| | Immunity, Active | 1 | 2017 | 8 | 0.530 |
Why?
| | Respiration, Artificial | 1 | 2021 | 713 | 0.470 |
Why?
| | Diabetes, Gestational | 2 | 2019 | 306 | 0.420 |
Why?
| | Meningitis | 2 | 2023 | 80 | 0.360 |
Why?
| | Registries | 1 | 2021 | 2406 | 0.360 |
Why?
| | Interleukin-6 | 1 | 2016 | 776 | 0.340 |
Why?
| | Inflammation | 3 | 2019 | 2878 | 0.330 |
Why?
| | Hospitalization | 1 | 2021 | 2460 | 0.330 |
Why?
| | Fibroblasts | 1 | 2016 | 1025 | 0.310 |
Why?
| | Monkeypox virus | 2 | 2023 | 23 | 0.240 |
Why?
| | Aquaporin 4 | 1 | 2024 | 101 | 0.210 |
Why?
| | Stiff-Person Syndrome | 1 | 2024 | 14 | 0.200 |
Why?
| | Medical Tourism | 1 | 2023 | 9 | 0.200 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2023 | 31 | 0.200 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2023 | 55 | 0.190 |
Why?
| | Neuromyelitis Optica | 1 | 2024 | 140 | 0.190 |
Why?
| | Encephalomyelitis | 1 | 2022 | 14 | 0.190 |
Why?
| | Exanthema | 1 | 2022 | 86 | 0.180 |
Why?
| | Encephalitis | 1 | 2023 | 142 | 0.180 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 110 | 0.170 |
Why?
| | New England | 1 | 2021 | 37 | 0.170 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2017 | 652 | 0.150 |
Why?
| | Immunoglobulin G | 1 | 2023 | 892 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 339 | 0.140 |
Why?
| | Mortality | 1 | 2021 | 378 | 0.140 |
Why?
| | Sexual and Gender Minorities | 1 | 2022 | 259 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 699 | 0.130 |
Why?
| | Chemokines | 1 | 2017 | 217 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1661 | 0.120 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2016 | 11 | 0.120 |
Why?
| | Dermis | 1 | 2016 | 31 | 0.120 |
Why?
| | Stress, Physiological | 1 | 2019 | 443 | 0.110 |
Why?
| | Pilot Projects | 1 | 2021 | 1891 | 0.110 |
Why?
| | Fetal Development | 2 | 2019 | 298 | 0.110 |
Why?
| | Risk Factors | 2 | 2021 | 10885 | 0.110 |
Why?
| | Fetus | 1 | 2019 | 804 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2016 | 389 | 0.100 |
Why?
| | Brain | 2 | 2017 | 2947 | 0.100 |
Why?
| | Sex Characteristics | 1 | 2019 | 782 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2930 | 0.100 |
Why?
| | Humans | 10 | 2024 | 145474 | 0.090 |
Why?
| | Male | 6 | 2024 | 72842 | 0.090 |
Why?
| | Placenta | 1 | 2019 | 786 | 0.090 |
Why?
| | Mothers | 1 | 2017 | 765 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2016 | 1217 | 0.080 |
Why?
| | Cohort Studies | 1 | 2021 | 6013 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3904 | 0.080 |
Why?
| | Pregnancy | 3 | 2019 | 7202 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5983 | 0.080 |
Why?
| | Cytokines | 1 | 2017 | 2067 | 0.070 |
Why?
| | Female | 6 | 2024 | 78844 | 0.070 |
Why?
| | Mitochondria | 1 | 2016 | 992 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2016 | 1356 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1767 | 0.070 |
Why?
| | Cells, Cultured | 1 | 2016 | 4148 | 0.070 |
Why?
| | Receptors, Glycine | 1 | 2024 | 5 | 0.050 |
Why?
| | Mice | 2 | 2019 | 18329 | 0.050 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2023 | 122 | 0.050 |
Why?
| | Middle Aged | 2 | 2024 | 36215 | 0.050 |
Why?
| | District of Columbia | 1 | 2022 | 38 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 300 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 412 | 0.040 |
Why?
| | Adult | 2 | 2024 | 40777 | 0.040 |
Why?
| | Astrocytes | 1 | 2023 | 228 | 0.040 |
Why?
| | Eosinophils | 1 | 2023 | 316 | 0.040 |
Why?
| | Homosexuality, Male | 1 | 2022 | 231 | 0.040 |
Why?
| | Animals | 3 | 2019 | 38030 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 628 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1061 | 0.030 |
Why?
| | Incidence | 1 | 2024 | 2923 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2865 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2019 | 266 | 0.030 |
Why?
| | Autoantibodies | 1 | 2023 | 1509 | 0.030 |
Why?
| | United States | 2 | 2024 | 16098 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1476 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2019 | 602 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 1038 | 0.020 |
Why?
| | Central Nervous System Stimulants | 1 | 2014 | 185 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4553 | 0.020 |
Why?
| | Nicotine | 1 | 2014 | 331 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 14218 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 17291 | 0.010 |
Why?
| | Analgesics, Opioid | 1 | 2014 | 1149 | 0.010 |
Why?
| | Obesity | 1 | 2019 | 3116 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 22529 | 0.010 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 1102 | 0.010 |
Why?
| | Aged | 1 | 2024 | 26153 | 0.010 |
Why?
|
|
Money's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|